MedPath

Diethylpropion Hydrochloride

Diethylpropion Hydrochloride Extended Release Tablets, 75 mgCIVRx only

Approved
Approval ID

89306917-a65b-40d4-9c51-d59ac0ad2017

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 28, 2023

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Diethylpropion Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71335-0049
Application NumberANDA091680
Product Classification
M
Marketing Category
C73584
G
Generic Name
Diethylpropion Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateDecember 20, 2019
FDA Product Classification

INGREDIENTS (7)

DIETHYLPROPION HYDROCHLORIDEActive
Quantity: 75 mg in 1 1
Code: 19V2PL39NG
Classification: ACTIB
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
CARBOMER HOMOPOLYMER TYPE A (ALLYL PENTAERYTHRITOL CROSSLINKED)Inactive
Code: F68VH75CJC
Classification: IACT
TARTARIC ACIDInactive
Code: W4888I119H
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POVIDONE K30Inactive
Code: U725QWY32X
Classification: IACT
HYPROMELLOSE ACETATE SUCCINATE 06081224 (3 MM2/S)Inactive
Code: 6N003M473W
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Diethylpropion Hydrochloride - FDA Drug Approval Details